---
title: "Antiverse: Antiverse develops AI-designed antibodies for challenging drug targets."
url: https://emrr.uz/antiverse?lang=uz
language: uz
updated: 2026-11-20T06:01:51Z
source: emrr (https://emrr.uz)
---

# Antiverse

Antiverse develops AI-designed antibodies for challenging drug targets.

[antiverse.io](https://www.antiverse.io/)

- **Soha**: Biotech
- **Tashkil etilgan**: 2017
- **Jamoa hajmi**: 10-49 xodim
- **Joylashuv**: Wales, United Kingdom

## Tasdiqlangan daromad: hali ulanmagan

Antiverse sizningmi? Ushbu sahifani soʻrang va Stripe, App Store yoki Google Play’ni ulang: MRR va oʻsishingiz shu yerda toʻgʻridan-toʻgʻri manbadan koʻrinadi.

[Sizniki boʻlsa, soʻrang](https://panel.emrr.uz/reserve/antiverse)

## Startap haqida

Antiverse is a techbio company specializing in the design of antibodies for difficult drug targets such as GPCRs and ion channels. Using advanced machine learning and cell line engineering, the company develops new antibody therapeutics aimed at enabling innovative treatments for patients. Headquartered in Cardiff, Wales, United Kingdom, with an office in Boston, Massachusetts, Antiverse combines biotechnology and AI to accelerate the discovery of next-generation therapies and bring life-changing medicines to patients.

## Jamoa

- **Murat Tunaboylu**, CEO & Co-founder (Asoschi)
- **Ben Holland**, Co-Founder & CTO (Asoschi)

## Auditoriya

Ijtimoiy tarmoqlardagi kuzatuvchilar

- [YouTube @antiversehq](https://www.youtube.com/@antiversehq): ≈55 obunachi (Ochiq raqam, emrr YouTubedan oʻqigan (yaxlitlangan), 2026-yil 20-noyabr)
- [X @antiversehq](https://x.com/antiversehq)
- [LinkedIn antiverse](https://www.linkedin.com/company/antiverse/)

Profil maʼlumotlari manbasi: Stanbase.

2026-yil 20-noyabr yangilangan

[Bu sahifa Markdown formatida](https://emrr.uz/antiverse.md?lang=uz)

[Tasdiqlangan sahifa ochish](https://emrr.uz/?lang=uz): Stripe, App Store yoki Google Play’ni ikki daqiqada ulang va xuddi shunday sahifaga ega boʻling. emrr har bir raqamni oʻzi oʻqiydi, shuning uchun investorlar raqamlaringizga ishonishi mumkin. $1,000 MRR’gacha bepul.
